Drug Shortage Report for MYLAN-ATORVASTATIN

Last updated on 2018-10-24 History
Report ID 19456
Drug Identification Number 02392976
Brand name MYLAN-ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90BT, 500BT
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-10-20
Actual start date
Estimated end date 2018-10-26
Actual end date 2018-10-23
Shortage status Resolved
Updated date 2018-10-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-08-15 English Compare
v2 2017-08-15 French Compare
v3 2017-09-08 English Compare
v4 2017-09-08 French Compare
v5 2017-09-11 English Compare
v6 2017-09-21 English Compare
v7 2017-09-21 French Compare
v8 2018-02-02 English Compare
v9 2018-02-02 French Compare
v10 2018-02-23 English Compare
v11 2018-02-23 French Compare
v12 2018-03-19 English Compare
v13 2018-03-19 French Compare
v14 2018-04-11 English Compare
v15 2018-04-11 French Compare
v16 2018-08-08 English Compare
v17 2018-08-08 French Compare
v18 2018-08-10 English Compare
v19 2018-08-15 English Compare
v20 2018-08-15 French Compare

Showing 1 to 20 of 78